{"prompt": "Please generate an operative report for a 54 year old female. We performed a therapeutic bronchoscopy with tumor debulking and placed a Boston Scientific Ultraflex 10x40mm cover stent in the Right Upper Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 54-year-old female who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 54-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 75 year old male. We performed a therapeutic bronchoscopy with tumor debulking and placed a AEROMini 6x15mm stent in the Left Upper Lobe. The Left Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 75-year-old male who presents with malignant airway obstruction and shortness of breath.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Infiltrating submucosal tumor with exophytic component and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 75-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of AEROMini 6x15mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "61yo F tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Right Lower Lobe, stent RUL (AEROMini 6x10mm stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 61-year-old female who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Infiltrating submucosal tumor with exophytic component and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 61-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of AEROMini 6x10mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 59 year old female. We performed a therapeutic bronchoscopy with tumor debulking and placed a Boston Scientific Ultraflex 10x40mm cover stent in the Right Middle Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 59-year-old female who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 59-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 64 year old female. We performed a therapeutic bronchoscopy with tumor debulking and placed a Boston Scientific Ultraflex 10x40mm cover stent in the Right Middle Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 64-year-old female who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 64-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Pt 67 F, malignant airway obstruction and shortness of breath. Procedure: APC, Balloon, Stent RML. Device: AEROMini 6x15mm stent. RML patency 10% -> 85%.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 67-year-old female who presents with malignant airway obstruction and shortness of breath.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 67-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x15mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 64 M\nIndication: respiratory failure secondary to central airway obstruction\nProcedure: Tumor excision, APC, Stenting\nTarget: Left Upper Lobe\nStent: Merit Endotek 8x20mm stent\nOutcome: LUL opened from 0% to 75%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 64-year-old male who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 64-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of Merit Endotek 8x20mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 61 year old female. We performed a therapeutic bronchoscopy with tumor debulking and placed a AEROMini 6x10mm stent in the Right Middle Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 61-year-old female who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 61-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x10mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "54yo F tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Right Lower Lobe, stent RUL (Merit Endotek 8x20mm stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 54-year-old female who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 54-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Merit Endotek 8x20mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 75 M\nIndication: bronchial stenosis related to endobronchial tumor\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Middle Lobe\nStent: Merit Endotek 8x20mm stent\nOutcome: RML opened from 5% to 90%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 75-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 75-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Merit Endotek 8x20mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "81yo M tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Left Lower Lobe, stent LUL (Merit Endotek 8x20mm stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 81-year-old male who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 81-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of Merit Endotek 8x20mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 81 year old female. We performed a therapeutic bronchoscopy with tumor debulking and placed a AEROMini 6x10mm stent in the Right Middle Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 81-year-old female who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 81-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x10mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 81 year old female. We performed a therapeutic bronchoscopy with tumor debulking and placed a AEROMini 6x10mm stent in the Right Middle Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 81-year-old female who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 81-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x10mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 54 year old male. We performed a therapeutic bronchoscopy with tumor debulking and placed a Merit Endotek 8x20mm stent in the Right Upper Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 54-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Infiltrating submucosal tumor with exophytic component and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 54-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Merit Endotek 8x20mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Codes: 31645, 31636 (RML stent), 31640, 31641. Dx J98.09. Pt 67/F. Stent used: AEROMini 6x10mm stent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 67-year-old female who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 67-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x10mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "72yo M tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Right Lower Lobe, stent RML (Merit Endotek 8x20mm stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 72-year-old male who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 72-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Merit Endotek 8x20mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Codes: 31645, 31636 (RUL stent), 31640, 31641. Dx J98.09. Pt 59/M. Stent used: Boston Scientific Ultraflex 10x40mm cover stent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 59-year-old male who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 59-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "81yo F tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Right Lower Lobe, stent RUL (Boston Scientific Ultraflex 10x40mm cover stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 81-year-old female who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 81-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 54 F\nIndication: respiratory failure secondary to central airway obstruction\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Upper Lobe\nStent: AEROMini 6x10mm stent\nOutcome: RUL opened from 10% to 85%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 54-year-old female who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 54-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of AEROMini 6x10mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 75 F\nIndication: bronchial stenosis related to endobronchial tumor\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Upper Lobe\nStent: Merit Endotek 8x20mm stent\nOutcome: RUL opened from 0% to 75%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 75-year-old female who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 75-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Merit Endotek 8x20mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 61 year old male. We performed a therapeutic bronchoscopy with tumor debulking and placed a AEROMini 6x15mm stent in the Right Middle Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 61-year-old male who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 61-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x15mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 67 M\nIndication: extrinsic compression and endobronchial tumor invasion\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Middle Lobe\nStent: Merit Endotek 8x20mm stent\nOutcome: RML opened from 0% to 75%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 67-year-old male who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 67-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Merit Endotek 8x20mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 54 F\nIndication: malignant airway obstruction and shortness of breath\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Upper Lobe\nStent: Merit Endotek 8x20mm stent\nOutcome: RUL opened from 5% to 90%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 54-year-old female who presents with malignant airway obstruction and shortness of breath.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 54-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Merit Endotek 8x20mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Codes: 31645, 31636 (LUL stent), 31640, 31641. Dx J98.09. Pt 54/M. Stent used: Merit Endotek 8x20mm stent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 54-year-old male who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 54-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of Merit Endotek 8x20mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 54 M\nIndication: bronchial stenosis related to endobronchial tumor\nProcedure: Tumor excision, APC, Stenting\nTarget: Left Upper Lobe\nStent: AEROMini 6x15mm stent\nOutcome: LUL opened from 1% to 80%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 54-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 54-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of AEROMini 6x15mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "81yo F tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Right Lower Lobe, stent RUL (Merit Endotek 8x20mm stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 81-year-old female who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 81-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Merit Endotek 8x20mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 54 F\nIndication: extrinsic compression and endobronchial tumor invasion\nProcedure: Tumor excision, APC, Stenting\nTarget: Left Upper Lobe\nStent: AEROMini 6x15mm stent\nOutcome: LUL opened from 1% to 80%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 54-year-old female who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 54-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of AEROMini 6x15mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Pt 72 F, extrinsic compression and endobronchial tumor invasion. Procedure: APC, Balloon, Stent RUL. Device: Boston Scientific Ultraflex 10x40mm cover stent. RUL patency 0% -> 75%.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 72-year-old female who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Infiltrating submucosal tumor with exophytic component and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 72-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "72yo M tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Right Lower Lobe, stent RUL (Merit Endotek 8x20mm stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 72-year-old male who presents with malignant airway obstruction and shortness of breath.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 72-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Merit Endotek 8x20mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Pt 64 F, bronchial stenosis related to endobronchial tumor. Procedure: APC, Balloon, Stent RUL. Device: Boston Scientific Ultraflex 10x40mm cover stent. RUL patency 10% -> 85%.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 64-year-old female who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 64-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 67 F\nIndication: respiratory failure secondary to central airway obstruction\nProcedure: Tumor excision, APC, Stenting\nTarget: Left Upper Lobe\nStent: AEROMini 6x15mm stent\nOutcome: LUL opened from 0% to 75%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 67-year-old female who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 67-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of AEROMini 6x15mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Pt 59 M, respiratory failure secondary to central airway obstruction. Procedure: APC, Balloon, Stent RUL. Device: AEROMini 6x10mm stent. RUL patency 10% -> 85%.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 59-year-old male who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 59-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of AEROMini 6x10mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 61 M\nIndication: bronchial stenosis related to endobronchial tumor\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Upper Lobe\nStent: AEROMini 6x10mm stent\nOutcome: RUL opened from 10% to 85%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 61-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Infiltrating submucosal tumor with exophytic component and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 61-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of AEROMini 6x10mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Pt 75 M, respiratory failure secondary to central airway obstruction. Procedure: APC, Balloon, Stent RML. Device: Boston Scientific Ultraflex 10x40mm cover stent. RML patency 5% -> 90%.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 75-year-old male who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 75-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 67 year old male. We performed a therapeutic bronchoscopy with tumor debulking and placed a AEROMini 6x15mm stent in the Left Upper Lobe. The Left Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 67-year-old male who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 67-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of AEROMini 6x15mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "72yo F tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Left Lower Lobe, stent LUL (Merit Endotek 8x20mm stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 72-year-old female who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 72-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of Merit Endotek 8x20mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 61 F\nIndication: bronchial stenosis related to endobronchial tumor\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Middle Lobe\nStent: AEROMini 6x10mm stent\nOutcome: RML opened from 5% to 90%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 61-year-old female who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 61-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x10mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "67yo F tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Left Lower Lobe, stent LUL (Boston Scientific Ultraflex 10x40mm cover stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 67-year-old female who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 67-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 61 M\nIndication: respiratory failure secondary to central airway obstruction\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Upper Lobe\nStent: AEROMini 6x15mm stent\nOutcome: RUL opened from 5% to 90%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 61-year-old male who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Infiltrating submucosal tumor with exophytic component and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 61-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of AEROMini 6x15mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 59 F\nIndication: malignant airway obstruction and shortness of breath\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Middle Lobe\nStent: AEROMini 6x15mm stent\nOutcome: RML opened from 10% to 85%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 59-year-old female who presents with malignant airway obstruction and shortness of breath.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 59-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x15mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "67yo M tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Left Lower Lobe, stent LUL (AEROMini 6x15mm stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 67-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 67-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of AEROMini 6x15mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 64 F\nIndication: bronchial stenosis related to endobronchial tumor\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Upper Lobe\nStent: Boston Scientific Ultraflex 10x40mm cover stent\nOutcome: RUL opened from 0% to 75%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 64-year-old female who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Infiltrating submucosal tumor with exophytic component and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 64-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 64 F\nIndication: malignant airway obstruction and shortness of breath\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Middle Lobe\nStent: AEROMini 6x15mm stent\nOutcome: RML opened from 1% to 80%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 64-year-old female who presents with malignant airway obstruction and shortness of breath.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 64-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x15mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 59 M\nIndication: malignant airway obstruction and shortness of breath\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Middle Lobe\nStent: Boston Scientific Ultraflex 10x40mm cover stent\nOutcome: RML opened from 10% to 85%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 59-year-old male who presents with malignant airway obstruction and shortness of breath.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Infiltrating submucosal tumor with exophytic component and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 59-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 81 F\nIndication: extrinsic compression and endobronchial tumor invasion\nProcedure: Tumor excision, APC, Stenting\nTarget: Left Upper Lobe\nStent: AEROMini 6x10mm stent\nOutcome: LUL opened from 1% to 80%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 81-year-old female who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 81-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of AEROMini 6x10mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 72 M\nIndication: bronchial stenosis related to endobronchial tumor\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Middle Lobe\nStent: AEROMini 6x10mm stent\nOutcome: RML opened from 5% to 90%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 72-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 72-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x10mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "54yo F tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Right Lower Lobe, stent RML (AEROMini 6x10mm stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 54-year-old female who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 54-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x10mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "81yo M tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Right Lower Lobe, stent RML (Boston Scientific Ultraflex 10x40mm cover stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 81-year-old male who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 81-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Codes: 31645, 31636 (RML stent), 31640, 31641. Dx J98.09. Pt 67/F. Stent used: AEROMini 6x15mm stent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 67-year-old female who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 67-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x15mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Codes: 31645, 31636 (LUL stent), 31640, 31641. Dx J98.09. Pt 54/M. Stent used: AEROMini 6x10mm stent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 54-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 54-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of AEROMini 6x10mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Codes: 31645, 31636 (LUL stent), 31640, 31641. Dx J98.09. Pt 61/F. Stent used: Boston Scientific Ultraflex 10x40mm cover stent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 61-year-old female who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 61-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Pt 81 F, bronchial stenosis related to endobronchial tumor. Procedure: APC, Balloon, Stent LUL. Device: AEROMini 6x15mm stent. LUL patency 5% -> 90%.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 81-year-old female who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 81-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of AEROMini 6x15mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "67yo F tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Left Lower Lobe, stent LUL (Merit Endotek 8x20mm stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 67-year-old female who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 67-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of Merit Endotek 8x20mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 72 year old female. We performed a therapeutic bronchoscopy with tumor debulking and placed a AEROMini 6x10mm stent in the Right Middle Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 72-year-old female who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 72-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x10mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Codes: 31645, 31636 (LUL stent), 31640, 31641. Dx J98.09. Pt 72/F. Stent used: Merit Endotek 8x20mm stent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 72-year-old female who presents with malignant airway obstruction and shortness of breath.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 72-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of Merit Endotek 8x20mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 72 year old female. We performed a therapeutic bronchoscopy with tumor debulking and placed a Boston Scientific Ultraflex 10x40mm cover stent in the Right Middle Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 72-year-old female who presents with malignant airway obstruction and shortness of breath.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 72-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 54 year old female. We performed a therapeutic bronchoscopy with tumor debulking and placed a Merit Endotek 8x20mm stent in the Right Upper Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 54-year-old female who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 54-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Merit Endotek 8x20mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Pt 75 M, bronchial stenosis related to endobronchial tumor. Procedure: APC, Balloon, Stent LUL. Device: Boston Scientific Ultraflex 10x40mm cover stent. LUL patency 5% -> 90%.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 75-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 75-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 81 M\nIndication: bronchial stenosis related to endobronchial tumor\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Middle Lobe\nStent: Merit Endotek 8x20mm stent\nOutcome: RML opened from 10% to 85%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 81-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 81-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Merit Endotek 8x20mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Pt 72 M, respiratory failure secondary to central airway obstruction. Procedure: APC, Balloon, Stent RML. Device: AEROMini 6x10mm stent. RML patency 1% -> 80%.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 72-year-old male who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 72-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x10mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 67 F\nIndication: respiratory failure secondary to central airway obstruction\nProcedure: Tumor excision, APC, Stenting\nTarget: Left Upper Lobe\nStent: Merit Endotek 8x20mm stent\nOutcome: LUL opened from 0% to 75%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 67-year-old female who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Infiltrating submucosal tumor with exophytic component and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 67-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of Merit Endotek 8x20mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "59yo F tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Right Lower Lobe, stent RUL (Boston Scientific Ultraflex 10x40mm cover stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 59-year-old female who presents with malignant airway obstruction and shortness of breath.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 59-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "64yo M tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Left Lower Lobe, stent LUL (Boston Scientific Ultraflex 10x40mm cover stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 64-year-old male who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 64-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Codes: 31645, 31636 (RML stent), 31640, 31641. Dx J98.09. Pt 72/M. Stent used: AEROMini 6x15mm stent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 72-year-old male who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 72-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x15mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 54 M\nIndication: extrinsic compression and endobronchial tumor invasion\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Middle Lobe\nStent: Merit Endotek 8x20mm stent\nOutcome: RML opened from 5% to 90%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 54-year-old male who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Infiltrating submucosal tumor with exophytic component and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 54-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Merit Endotek 8x20mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 81 F\nIndication: extrinsic compression and endobronchial tumor invasion\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Upper Lobe\nStent: Boston Scientific Ultraflex 10x40mm cover stent\nOutcome: RUL opened from 10% to 85%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 81-year-old female who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 81-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 64 M\nIndication: bronchial stenosis related to endobronchial tumor\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Middle Lobe\nStent: Merit Endotek 8x20mm stent\nOutcome: RML opened from 1% to 80%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 64-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Infiltrating submucosal tumor with exophytic component and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 64-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Merit Endotek 8x20mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "67yo M tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Right Lower Lobe, stent RUL (Merit Endotek 8x20mm stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 67-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 67-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Merit Endotek 8x20mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "64yo M tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Right Lower Lobe, stent RML (Merit Endotek 8x20mm stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 64-year-old male who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 64-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Merit Endotek 8x20mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Pt 64 M, respiratory failure secondary to central airway obstruction. Procedure: APC, Balloon, Stent RUL. Device: Merit Endotek 8x20mm stent. RUL patency 1% -> 80%.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 64-year-old male who presents with respiratory failure secondary to central airway obstruction.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 64-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Merit Endotek 8x20mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 59 M\nIndication: bronchial stenosis related to endobronchial tumor\nProcedure: Tumor excision, APC, Stenting\nTarget: Left Upper Lobe\nStent: AEROMini 6x15mm stent\nOutcome: LUL opened from 5% to 90%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 59-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 5% patent to 90% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 59-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of AEROMini 6x15mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Pt 81 M, malignant airway obstruction and shortness of breath. Procedure: APC, Balloon, Stent RUL. Device: AEROMini 6x10mm stent. RUL patency 0% -> 75%.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 81-year-old male who presents with malignant airway obstruction and shortness of breath.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 81-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of AEROMini 6x10mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 75 year old male. We performed a therapeutic bronchoscopy with tumor debulking and placed a Merit Endotek 8x20mm stent in the Left Upper Lobe. The Left Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 75-year-old male who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Left Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - LUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and LUL orifice.\nLUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nLeft Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and LUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and LUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nLeft Upper Lobe Management:\nAfter tumor excision and ablation, the LUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of LB3 (apical-posterior) was confirmed; LB4 (lingular) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the LUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the LUL (LB3, LB4, and LB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the LUL bronchus. It seated very well and maintained patency of both LB3, LB4, and LB5 segments.\n\nLeft Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Left Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. LUL): Improved from 60% patent to 90% patent.\nLUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nLUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 75-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and LUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and LUL.\nStent: Placement of Merit Endotek 8x20mm stent in LUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 61 M\nIndication: bronchial stenosis related to endobronchial tumor\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Middle Lobe\nStent: AEROMini 6x10mm stent\nOutcome: RML opened from 10% to 85%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 61-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 61-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x10mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "54yo F tumor stenosis. rigid bronchsopy consideration. interventions: apc, balloon Right Lower Lobe, stent RUL (AEROMini 6x10mm stent). bal sent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 54-year-old female who presents with extrinsic compression and endobronchial tumor invasion.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 54-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of AEROMini 6x10mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 75 year old female. We performed a therapeutic bronchoscopy with tumor debulking and placed a AEROMini 6x10mm stent in the Right Upper Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 75-year-old female who presents with malignant airway obstruction and shortness of breath.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Fleshy, polypoid endobronchial mass and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x10mm stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 75-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of AEROMini 6x10mm stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Patient: 67 M\nIndication: bronchial stenosis related to endobronchial tumor\nProcedure: Tumor excision, APC, Stenting\nTarget: Right Upper Lobe\nStent: Boston Scientific Ultraflex 10x40mm cover stent\nOutcome: RUL opened from 1% to 80%", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 67-year-old male who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RUL bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Infiltrating submucosal tumor with exophytic component and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RUL orifice.\nRUL: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RUL. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RUL was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Upper Lobe Management:\nAfter tumor excision and ablation, the RUL bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB1 (apical) was confirmed; RB2 (posterior) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RUL stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RUL (RB1, RB2, and RB3) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RUL bronchus. It seated very well and maintained patency of both RB1, RB2, and RB3 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RUL): Improved from 60% patent to 90% patent.\nRUL Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRUL BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 67-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RUL stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RUL.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RUL bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Codes: 31645, 31636 (RML stent), 31640, 31641. Dx J98.09. Pt 67/F. Stent used: Boston Scientific Ultraflex 10x40mm cover stent.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 67-year-old female who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Infiltrating submucosal tumor with exophytic component and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Boston Scientific Ultraflex 10x40mm cover stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 0% patent to 75% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 67-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Boston Scientific Ultraflex 10x40mm cover stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 72 year old female. We performed a therapeutic bronchoscopy with tumor debulking and placed a AEROMini 6x15mm stent in the Right Middle Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 72-year-old female who presents with bronchial stenosis related to endobronchial tumor.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Extensive partially obstructing vascular endobronchial tumor and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An AEROMini 6x15mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 1% patent to 80% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 72-year-old female who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of AEROMini 6x15mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
{"prompt": "Please generate an operative report for a 61 year old male. We performed a therapeutic bronchoscopy with tumor debulking and placed a Merit Endotek 8x20mm stent in the Right Middle Lobe. The Right Lower Lobe was also dilated.", "completion": "NOTE_ID: note_069\nSOURCE_FILE: note_069.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\nINDICATION FOR OPERATION: The patient is a 61-year-old male who presents with malignant airway obstruction and shortness of breath.\n\nThe nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT: Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient. Informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPOSTOPERATIVE DIAGNOSIS\nJ98.09 Other diseases of bronchus, not elsewhere classified\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31622 Dx bronchoscope/cell washing\n31624 Dx bronchoscope/lavage (BAL)\n31625 Endobronchial Biopsy(s)\n31630 Balloon dilation - Right Lower Lobe bronchus (no stent placed)\n31636 Dilate and bronchial stent initial bronchus - RML bronchus (dilation and stent placement)\n31640 Bronchoscopy with excision\n31641 Destruction of tumor OR relief of stenosis by any method other than excision (eg. laser therapy, cryotherapy)\n\nANESTHESIA: General Anesthesia\n\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Flexible Hybrid (Pediatric) Bronchoscope.\n\nESTIMATED BLOOD LOSS: Minimal\n\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL:\nA timeout was performed (confirming the patient's name, procedure type, and procedure location). Sedation was initiated and an LMA was placed.\n\nInitial Airway Inspection: The Flexible Therapeutic Bronchoscope was advanced for airway examination. Endobronchial topical lidocaine was applied to the vocal cords, main carina, right carina 1, and left carina 2.\n\nLarynx/Vocal Cords: No lesions; normal movement without mass.\n\nTrachea/Bronchi: Friable, necrotic tumor with white debris and overlying white necrotic debris were noted involving the mid-trachea, distal trachea, main carina, and lobar bronchi.\n\nSeverity: Obstruction was most severe at the distal trachea and RML orifice.\nRML: Highly stenotic and completely obstructed by tumor, debris, and mucus; unable to traverse initially.\nRight Lower Lobe: Moderate stenosis due to tumor and extrinsic compression.\n\nTherapeutic Interventions\n\nTherapeutic Aspiration: Secretions were moderate, thin, and clear. Successful therapeutic aspiration was performed to clear mucus and overlying necrotic debris from the trachea and mainstem bronchi.\n\nEndobronchial Biopsy: Biopsies were performed at tumor sites in the trachea, main carina, and RML. These were combined into a single sample labeled \"trachea\".\n\nTumor Excision: The obstructing tumor at the trachea, main carina, and RML was excised with mechanical debridement using bland alligator forceps.\n\nTumor Ablation (APC): Tumor destruction was performed using a 1.5mm Pulmonary axial 'straight-fire' probe (forcedAPC, 0.5 LPM, Max Watts 30-40) in 1-5 second bursts. Extensive tumor ablation and hemostasis were achieved.\n\nRight Middle Lobe Management:\nAfter tumor excision and ablation, the RML bronchus was traversed with a Hybrid bronchoscope and saline hydrodissection. Patency of RB4 (lateral) was confirmed; RB5 (medial) appeared viable but filled with debris.\n\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the RML stenosis to 7 mm (2 inflations, 60 and 30 seconds). The therapeutic scope could then traverse with moderate pressure.\n\nBronchoalveolar Lavage (BAL): Performed at the RML (RB4 and RB5) with 60 cc instilled and 15 cc returned.\n\nStent Placement: An Merit Endotek 8x20mm stent was placed in the RML bronchus. It seated very well and maintained patency of both RB4 and RB5 segments.\n\nRight Lower Lobe Management:\nBalloon Dilation: A 6/7/8 mm Elation balloon was used to dilate the Right Lower Lobe bronchus take-off to 8 mm (1 inflation, 60 seconds).\n\nResults and Patency\nTrachea: Improved from 80% patent to 95% patent.\nRight-sided airways (excl. RML): Improved from 60% patent to 90% patent.\nRML Bronchus: Improved from 10% patent to 85% patent.\nLeft Mainstem: Improved from 80% patent to 95% patent.\n\nResidual secretions, saline, and blood were suctioned to clear. The patient tolerated the procedure well. The LMA was removed in the operating room.\n\nSPECIMENS\nEndobronchial biopsy (combined samples): Pathology\nRML BAL: Cell count, micro/cultures, cytology\n\nIMPRESSION/PLAN\nThe patient is a 61-year-old male who underwent bronchoscopy for endobronchial tumor excision/ablation, airway dilation, and RML stent placement.\n\nIntervention: Extensive endobronchial tumor excision and ablation in the trachea and RML.\nStent: Placement of Merit Endotek 8x20mm stent in RML bronchus.\n\nPost-Procedure Care:\nFollow-up post-op CXR.\nAwait EBBx and BAL results.\nStent hydration/hygiene protocol: QID albuterol nebulizer, hypertonic saline (3%, 4mL) nebulizer, and flutter valve regimen; Mucinex 1200mg BID for mucolysis.\nEngage case management to obtain devices/meds prior to discharge.\n\nFollow-up: Repeat bronchoscopy with airway evaluation, stent check, and likely additional tumor excision/ablation in ~3-4 weeks. Consideration of rigid bronchoscopy with micro-debrider given extensive involvement.\n"}
